Wynnewood, PA, United States of America

Wei Guo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Guo. Retrieved from https://idiyas.com/inventor/wei-guo-r1ho2a5b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei Guo: Innovator in Cancer Diagnosis and Treatment

Introduction

Wei Guo is a prominent inventor based in Wynnewood, PA (US). He has made significant contributions to the field of cancer research, particularly in the area of diagnostics and treatment. His innovative work focuses on the use of extracellular vesicle proteins to enhance cancer care.

Latest Patents

Wei Guo holds a patent for "Extracellular vesicle proteins and their use for cancer diagnosis, predicting response to therapy, and treatment." This patent outlines compositions and methods for treating cancer patients. It also identifies patients with malignancies who are likely to respond to anti-PD-1/PD-L1 therapies and other immune-modulating treatments. He has 1 patent to his name.

Career Highlights

Wei Guo is affiliated with the University of Pennsylvania, where he conducts research and develops innovative solutions for cancer treatment. His work has the potential to significantly impact patient outcomes and improve therapeutic strategies.

Collaborations

Wei Guo collaborates with esteemed colleagues, including Gang Chen and Xiaowei Xu. Their combined expertise enhances the research efforts at the University of Pennsylvania.

Conclusion

Wei Guo's contributions to cancer diagnosis and treatment exemplify the importance of innovation in healthcare. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…